BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23076219)

  • 1. Mitosis-targeted anti-cancer therapies: where they stand.
    Chan KS; Koh CG; Li HY
    Cell Death Dis; 2012 Oct; 3(10):e411. PubMed ID: 23076219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target driven preclinical screening for new antimitotic chemotherapy agents.
    Novío S; Freire-Garabal M; Núñez MJ
    Curr Top Med Chem; 2014; 14(20):2263-71. PubMed ID: 25434356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.
    Eckerdt F; Strebhardt K
    Cancer Res; 2006 Jul; 66(14):6895-8. PubMed ID: 16849530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimitotic drugs in cancer chemotherapy: promises and pitfalls.
    Marzo I; Naval J
    Biochem Pharmacol; 2013 Sep; 86(6):703-10. PubMed ID: 23886991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage.
    Zeng X; Sigoillot F; Gaur S; Choi S; Pfaff KL; Oh DC; Hathaway N; Dimova N; Cuny GD; King RW
    Cancer Cell; 2010 Oct; 18(4):382-95. PubMed ID: 20951947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCL1 meets its end during mitotic arrest.
    Millman SE; Pagano M
    EMBO Rep; 2011 May; 12(5):384-5. PubMed ID: 21475247
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.
    Moshe Y; Boulaire J; Pagano M; Hershko A
    Proc Natl Acad Sci U S A; 2004 May; 101(21):7937-42. PubMed ID: 15148369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.
    Harley ME; Allan LA; Sanderson HS; Clarke PR
    EMBO J; 2010 Jul; 29(14):2407-20. PubMed ID: 20526282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLK1 inhibitors: setting the mitotic death trap.
    Plyte S; Musacchio A
    Curr Biol; 2007 Apr; 17(8):R280-3. PubMed ID: 17437704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stalling in mitosis and releasing the apoptotic brake.
    Kurokawa M; Kornbluth S
    EMBO J; 2010 Jul; 29(14):2255-7. PubMed ID: 20648046
    [No Abstract]   [Full Text] [Related]  

  • 11. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.
    Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A
    Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future prospects for mitosis-targeted antitumor therapies.
    Serrano-Del Valle A; Reina-Ortiz C; Benedi A; Anel A; Naval J; Marzo I
    Biochem Pharmacol; 2021 Aug; 190():114655. PubMed ID: 34129859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Mitosis in Cancer: Emerging Strategies.
    Dominguez-Brauer C; Thu KL; Mason JM; Blaser H; Bray MR; Mak TW
    Mol Cell; 2015 Nov; 60(4):524-36. PubMed ID: 26590712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property.
    Nguyen HG; Chinnappan D; Urano T; Ravid K
    Mol Cell Biol; 2005 Jun; 25(12):4977-92. PubMed ID: 15923616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via the ubiquitin-proteasome pathway.
    Li R; Wan B; Zhou J; Wang Y; Luo T; Gu X; Chen F; Yu L
    PLoS One; 2012; 7(9):e45932. PubMed ID: 23029325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability.
    Raab M; Sanhaji M; Zhou S; Rödel F; El-Balat A; Becker S; Strebhardt K
    Neoplasia; 2019 Apr; 21(4):363-375. PubMed ID: 30851646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processive ubiquitin chain formation by the anaphase-promoting complex.
    Meyer HJ; Rape M
    Semin Cell Dev Biol; 2011 Aug; 22(6):544-50. PubMed ID: 21477659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomponent reactions in antimitotic drug discovery.
    Cores A; Carbajales C; Coelho A
    Curr Top Med Chem; 2014; 14(20):2209-30. PubMed ID: 25440494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anaphase-promoting complex/cyclosome: APC/C.
    Acquaviva C; Pines J
    J Cell Sci; 2006 Jun; 119(Pt 12):2401-4. PubMed ID: 16763193
    [No Abstract]   [Full Text] [Related]  

  • 20. Polo-like kinase-1 controls Aurora A destruction by activating APC/C-Cdh1.
    van Leuken R; Clijsters L; van Zon W; Lim D; Yao X; Wolthuis RM; Yaffe MB; Medema RH; van Vugt MA
    PLoS One; 2009; 4(4):e5282. PubMed ID: 19390576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.